HOUSE_OVERSIGHT_024850.jpg
950 KB
Extraction Summary
1
People
6
Organizations
1
Locations
0
Events
1
Relationships
4
Quotes
Document Information
Type:
Market research report / financial analysis
File Size:
950 KB
Summary
This document is page 34 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the packaging and pricing of CBD gummy products from four different companies: CV Sciences, Green Roads, Highline Wellness, and cbdMD. The document bears a 'HOUSE_OVERSIGHT_024850' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though the content appears to be standard equity research unrelated to criminal activity.
People (1)
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Named in the watermark as the intended recipient of the report (michael.cella@cowen.com).
|
Organizations (6)
| Name | Type | Context |
|---|---|---|
| Cowen |
Financial services firm that produced the Collaborative Insights report.
|
|
| CV Sciences |
Company whose product is analyzed in Figure 44.
|
|
| Green Roads |
Company whose product is analyzed in Figure 45.
|
|
| Highline Wellness |
Company whose product is analyzed in Figure 46.
|
|
| cbdMD |
Company whose product is analyzed in Figure 47.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024850'.
|
Locations (1)
| Location | Context |
|---|---|
|
Label on cbdMD bottle says 'MADE IN THE U.S.A.'
|
Relationships (1)
Email address michael.cella@cowen.com indicates he is an employee or client receiving proprietary reports.
Key Quotes (4)
"CV Sciences Gummies Are Priced At A Premium"Source
HOUSE_OVERSIGHT_024850.jpg
Quote #1
"Green Roads' 300 MG Gummies Retail For $55"Source
HOUSE_OVERSIGHT_024850.jpg
Quote #2
"Highline Is Priced Competitively"Source
HOUSE_OVERSIGHT_024850.jpg
Quote #3
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."Source
HOUSE_OVERSIGHT_024850.jpg
Quote #4
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document